Abstract
Microsomal epoxide hydrolase is a biotransformation enzyme which is involved in the hydrolysis of various epoxides and epoxide intermediates. In the present study, its distribution was investigated in both normal human tissues and human tumours of different histogenetic origin using immunohistochemical techniques. In normal tissue, epithelial cells were more often and more intensely immunostained than mesenchymal cells. The main epithelial cell types expressing microsomal epoxide hydrolase were hepatocytes, acinus cells of the pancreas, and cells of salivary and adrenal glands. Immunostained cells of mesenchymal origin included monocytes, fibrocytes, fibroblasts, vessel endothelium, muscle cells, and cells of the reproductive system. Three patterns of expression were observed in tumour tissues: (1) moderate or strong in hepatocellular carcinomas, tumours of the adrenal gland, and theca-fibromas of the ovary; (2) inhomogeneous staining pattern of variable intensity in breast cancer, lung cancer, colorectal carcinomas, carcinoid tumours, and some tumours of mesenchymal origin; and (3) no expression in malignant melanomas, malignant lymphomas, and renal carcinomas. These data indicate that microsomal epoxide hydrolase expression is not restricted to tissue of any particular histogenetic origin. Nonetheless, immunohistochemical identification of microsomal epoxide hydrolase may be helpful in some well-defined histological settings, for example, confirmation of hepatocellular carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beaune P, Kremers F, Letawe-Goujon F, Gielen JE (1985) Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol 34: 3547–3552.
Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KA, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219–229.
Cowan KH, Batist G, Tulpule A, Sinha BK, Myers CE (1986) Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats. Proc Natl Acad Sci USA 83: 9328–9332.
De Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH (1990) Cytochrome P-450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253: 387–394.
Farin FM, Omiecinski CJ (1993) Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue. J Toxicol Environ Health 40: 317–335.
Fritz P, Behrle E, Beaune P, Eichelbaum M, Kroemer HK (1993) Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P450 3A and glutathione-S-transferase. Histochemistry 99: 443–451.
Fritz P, Behrle E, Zanger UM, Mürdter T, Schwarzmann P, Kroemer HK (1996) Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approach. Xenobiotica 26: 107–116.
Fritz P, Mürdter TE, Eichelbaum M, Siegle I, Weissert M, Zanger UM (2001) Microsomal epoxide hydrolase expression is a novel prognosis factor and predictor of tamoxifen response. J Clin Oncol 19: 3–9.
Fritz P, Sperker B, Mürdter TE, Spath M, Schwarzmann P, Kroemer HK, Eichelbaum M, Kivistö KT (1999) Quantitative immunohistochemical analysis of the glutathione S-transferase GSTM1: in situ phenotyping in archival material. Xenobiotica 29: 693–702.
Hattori N, Fujiwara H, Maeda M, Fujii S, Ueda M(2000) Epoxide hydrolase affects estrogen production in the human ovary. Endocrinology 141: 3353–3365.
Hsu SM, Raine L, Fanger H (1981) The use of anti-avidin antibody and avidin–biotin-complex in immunoperoxidase techniques. Am J Clin Pathol 75: 816–821.
Kawabata T, Guengerich FP, Baron J (1981) An immunohistochemical study on the localization and distribution of epoxide hydrolase within livers of untreated rats. Mol Pharmacol 20: 709–714.
Mckay JA, Murray GI, Weaver RJ, Ewen SW, Melvin WT, Burke MD (1993) Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut 34: 1234–1239.
Mckay JA, Weaver RJ, Murray GI, Ewen SW, Melvin WT, Burke MD (1995) Localization of microsomal epoxide hydrolase in normal and neoplastic human kidney. J Histochem Cytochem 43: 615–620.
Mesange F, Sebbar M, Kedjouar B, Capdevielle J, Guillemot JC, Ferrara P, Bayard F, Delarue F, Faye JC, Poirot M (1998) Microsomal epoxide hydrolase of rat liver is a subunit of the anti-oestrogen-binding site. Biochem J 334: 107–112.
Murray GI, Paterson PJ, Weaver RJ, Ewen SW, Melvin WT, Burke MD (1993a) The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma. Cancer 71: 36–43.
Murray GI, Taylor VE, Mckay JA, Weaver RJ, Ewen SW, Melvin WT, Burke MD (1995a) Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder. Int J Exp Pathol 76: 271–276.
Murray GI, Taylor VE, Mckay JA, Weaver RJ, Ewen SW, Melvin WT, Burke MD (1995b) The immunohistochemical localization of drugmetabolizing enzymes in prostate cancer. J Pathol 177: 147–152.
Murray GI, Weaver RJ, Paterson PJ, Ewen SW, Melvin WT, Burke MD (1993b) Expression of xenobiotic metabolizing enzymes in breast cancer. J Pathol 169: 347–353.
Omiecinski CJ, Aicher L, Swenson L (1994) Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther 269: 417–423
Pacifici GM, Franchi M, Gervasi PG, Longo V, DI Simplicio P, Temellini A, Giuliani L (1989) Profile of drug-metabolizing enzymes in human ileum and colon. Pharmacology 38: 137–145.
Philip PA, Kaklamanis L, Ryley N, Stratford I, Wolf R, Harris A, Carmichael J (1994) Expression of xenobiotic-metabolizing enzymes by primary and secondary hepatic tumours in man. Int J Radiat Oncol Biol Phys 29: 277–283.
Seidegård J, Depierre JW (1983) Microsomal epoxide hydrolase. Properties, regulation and function. Biochim Biophys Acta 695: 251–270.
Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, Gelboin HV (1994) The role of 12 cDNA-expressed human, rodent and rabbit cytochromes P450 in the metabolism of benzo(a)pyrene and benzo(a)pyrene trans-7,8-dihydrodiol. Mol Carcinogen 10: 159–168.
Skoda RC, Demierre A, Mcbride OW, Gonzalez FJ, Meyer UA (1988) Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. J Biol Chem 263: 1549–1554.
Snyder R, Chepiga T, Yang CS, Thomas H, Platt K, Oesch F (1993) Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone. Toxicol Appl Pharmacol 122: 172–181.
Wang H, Pevsner J (1999) Detection of endogenous biotin in various tissues: novel functions in the hippocampus and implications for its use in avidin–biotin technology. Cell Tissue Res 296: 511–516.
Wood AW, Wislocki PG, Chang RL, Levin W, Lu AY, Yagi J, Hernandez O, Herina DM, Conney AH (1976) Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides. Cancer Res 36: 3358–3366.
Zanger UM, Hauri HP, Loeper J, Homberg JC, Meyero UA (1988) Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci USA 85: 8256–8260.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coller, J.K., Fritz, P., Zanger, U.M. et al. Distribution of Microsomal Epoxide Hydrolase in Humans: An Immunohistochemical Study in Normal Tissues, and Benign and Malignant Tumours. Histochem J 33, 329–336 (2001). https://doi.org/10.1023/A:1012414806166
Issue Date:
DOI: https://doi.org/10.1023/A:1012414806166